Literature DB >> 28729778

Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions.

Shanshan Yin1, Qiuli Cui1, Kun Yan1, Wei Yang1, Wei Wu1, Liping Bao1, Minhua Chen1.   

Abstract

OBJECTIVE: To investigate differential diagnosis between intrahepatic cholangiocarcinoma (ICC) and arterial phase enhanced hepatic inflammatory lesions in patients without liver cirrhosis using contrast-enhanced ultrasound (CEUS).
METHODS: ICC and hepatic inflammatory lesions cases with CEUS and pathological diagnosis between Sep 2013 and Oct 2016 were investigated retrospectively. Imaging features of conventional ultrasound and CEUS were analyzed. The parameters of time intensity curve (TIC), including the arrival time, peak intensity (PI) in the lesions, the starting time for washout, and the intensity difference at 3 min (ΔI3) after contrast agent infection between the lesion and the liver parenchyma, were compared between ICC and hepatic inflammatory lesions.
RESULTS: Twenty-five ICC and fifteen inflammatory patients were included in this study. Seventeen ICC (68.0%) and two inflammatory cases (13.3%) showed bile duct dilatation on conventional ultrasound. Using CEUS, three ICC cases (12.0%) were misdiagnosed as inflammatory lesions and three inflammatory lesions (20.0%) as ICC; two ICC (8.0%) and one inflammatory case (6.7%) could not be made definite diagnosis. Washout started at 34.5±3.5 s and 61.5±12.9 s for ICC and inflammatory lesions respectively (P<0.001). The intensity difference between lesion and liver parenchyma at 3 min after contrast agent injection was 10.8±3.1 dB in ICC and 4.2±2.3 dB in inflammatory group (P<0.001). The sensitivity and specificity differentiating ICC and inflammatory lesions were 76% and 87% if the cut-off value of the intensity difference was 7.7 dB.
CONCLUSIONS: Combined with TIC analysis, and particularly with the characteristic of the early-starting and obvious washout in ICC, CEUS can be useful in differential diagnosis between hepatic inflammatory lesions and ICC.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; contrast enhanced ultrasound; inflammatory lesions; ultrasound

Year:  2017        PMID: 28729778      PMCID: PMC5497214          DOI: 10.21147/j.issn.1000-9604.2017.03.13

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  16 in total

1.  The nodular form of hepatic tuberculosis: contrast-enhanced ultrasonographic findings with pathologic correlation.

Authors:  Bing-Sheng Cao; Xiao-Lin Li; Ning Li; Zhong-Yuan Wang
Journal:  J Ultrasound Med       Date:  2010-06       Impact factor: 2.153

2.  Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.

Authors:  L-D Chen; H-X Xu; X-Y Xie; M-D Lu; Z-F Xu; G-J Liu; J-Y Liang; M-X Lin
Journal:  Br J Radiol       Date:  2008-11       Impact factor: 3.039

3.  Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  Michel Claudon; Christoph F Dietrich; Byung Ihn Choi; David O Cosgrove; Masatoshi Kudo; Christian P Nolsøe; Fabio Piscaglia; Stephanie R Wilson; Richard G Barr; Maria C Chammas; Nitin G Chaubal; Min-Hua Chen; Dirk Andre Clevert; Jean Michel Correas; Hong Ding; Flemming Forsberg; J Brian Fowlkes; Robert N Gibson; Barry B Goldberg; Nathalie Lassau; Edward L S Leen; Robert F Mattrey; Fuminori Moriyasu; Luigi Solbiati; Hans-Peter Weskott; Hui-Xiong Xu
Journal:  Ultrasound Med Biol       Date:  2012-11-05       Impact factor: 2.998

4.  Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.

Authors:  H-X Xu; L-D Chen; L-N Liu; Y-F Zhang; L-H Guo; C Liu
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

5.  LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.

Authors:  B Schellhaas; D Wildner; L Pfeifer; R S Goertz; A Hagel; M F Neurath; D Strobel
Journal:  Ultraschall Med       Date:  2016-08-03       Impact factor: 6.548

6.  Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.

Authors:  YuQiong Li; Hui Wang; DaPeng Li; JingYi Hu; Hao Wang; DongXun Zhou; QiaoMei Li; XiaoLan Jiang; HuaBang Zhou; HePing Hu
Journal:  J Clin Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 3.062

7.  Cholangiocellular Carcinoma.

Authors:  Arndt Vogel; Anna Saborowski
Journal:  Digestion       Date:  2017-03-14       Impact factor: 3.216

8.  Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.

Authors:  Wei Wu; Minhua Chen; Kun Yan; Yin Dai; Shanshan Yin; Wei Yang; Zhihui Fan
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

9.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 10.  Surveillance in cholangiocellular carcinoma.

Authors:  Thomas C Wirth; Arndt Vogel
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-11-14       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.